help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
The Oncologist, Vol. 1, No. 6, 398–398, December 1996
© 1996 AlphaMed Press

SPECIAL SECTION
PATIENT CARE

From The Bethesda Post

The Oncologist is pleased to feature news FROM THE BETHESDA POST, featuring high-priority National Cancer Institute clinical trials which are now accruing patients at the National Institutes of Health Clinical Center. There will be information on how to refer patients who may benefit from experimental cancer treatments. Once accepted on protocol, participating patients receive experimental treatment as well as travel to Bethesda free of charge.

Watch for forthcoming POSTS from Berlin, Amsterdam, Boston and around the globe in future issues of The Oncologist.






HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 1996 by AlphaMed Press.